Appearance:White or white crystalline powder, odourless
Synopsis：Tamoxifen citrate is a kind of estrogen competitive antagonist, which is a non steroidal anti estrogen drug. It can compete with estrogen in vivo and combine with estrogen receptor of breast cancer cells, so as to inhibit the effect of estrogen on cancer cells, hinder the growth and development of tumor cells, and play an anti-cancer effect. It is commonly used in the treatment of various types of breast cancer. It is especially suitable for women with postmenopausal breast cancer who have estrogen receptor and progesterone receptor positive and low level of prostate specific antigen.
Structural formula:
Properties
Summary
Tamoxifen citrate is a kind of estrogen competitive antagonist, which is a non steroidal anti estrogen drug. It can compete with estrogen in vivo and combine with estrogen receptor of breast cancer cells, so as to inhibit the effect of estrogen on cancer cells, hinder the growth and development of tumor cells, and play an anti-cancer effect. It is commonly used in the treatment of various types of breast cancer. It is especially suitable for women with postmenopausal breast cancer who have estrogen receptor and progesterone receptor positive and low level of prostate specific antigen.
Manufacturing
